European Life Science Tools and Reagents Market: Strategies for Growth and Innovation
26 nov. 2024 12h34 HE
|
BCC Research LLC
Boston, Nov. 26, 2024 (GLOBE NEWSWIRE) -- “According to the latest study from Research, “European Life Science Tools and Reagents Market,” the market for COVID-19 diagnostics products was $14.7...
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
25 nov. 2024 16h00 HE
|
Autonomix Medical, Inc.
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
25 nov. 2024 08h21 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of the...
Corline Biomedical AB omförhandlar avtal med Imperative Care för att bredda kundbearbetningen inom neurovaskulära CHS™-applikationer
20 nov. 2024 06h14 HE
|
Corline Biomedical AB
Corline Biomedical AB (”Corline”) meddelar att man tagit initiativ till omförhandling av avtalet med Imperative Care gällande CHS™ för neurovaskulära applikationer. Avtalet är från och med nu...
SurgiBox Announces Strategic Partnership with Accord International to Expand into Japanese Market
17 nov. 2024 18h17 HE
|
SurgiBox
TOKYO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- SurgiBox Inc., a leader in portable surgical solutions, is thrilled to announce a strategic partnership with Japanese medical distribution company, Accord...
Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel
14 nov. 2024 13h10 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its...
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21
14 nov. 2024 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
electroCore Announces Third Quarter 2024 Financial Results
13 nov. 2024 16h01 HE
|
electroCore, Inc.
Record quarterly revenues driven by 75% YoY growth of Rx gammaCore™ in the VA/DoD and 147% increase in Truvaga™ sales Company to host a conference call and webcast today, November 13, 2024 at...
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
12 nov. 2024 08h00 HE
|
Acuitive Technologies
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
07 nov. 2024 16h05 HE
|
CytoSorbents
PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...